Clinical trial / 2013
An integrative medicine program including fasting therapy improved fibromyalgia outcomes more than conventional medicine at 2 weeks, but not at 12 weeks.
A controlled, nonrandomized pilot study compared an inpatient integrative medicine (IM) approach including fasting therapy and Mind-Body-Medicine (n=28) against a conventional rheumatology (CM) approach (n=20) for fibromyalgia. At the end of the 2-week hospital stay, the IM group showed significant improvements in the Fibromyalgia Impact Questionnaire score compared to the CM group (P < 0.014), along with most secondary outcomes. However, after 12 weeks, the beneficial effects of the IM approach were reduced and no longer statistically significant, except for anxiety.
- Study type
- Controlled nonrandomized pilot study
- Who was studied
- 48 consecutive inpatients with fibromyalgia (28 treated with IM, 20 with CM)
- What was measured
- Change in Fibromyalgia Impact Questionnaire (FIQ) score at 2 weeks and 12 weeks, plus pain, depression, anxiety, and well being
THE PAPER
In-Patient Treatment of Fibromyalgia: A Controlled Nonrandomized Comparison of Conventional Medicine versus Integrative Medicine including Fasting Therapy.
Michalsen A, Li C, Kaiser K, Lüdtke R, Meier L, Stange R, Kessler C. Evid Based Complement Alternat Med, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.